Nagaraju Bandaru – författare
Visar alla böcker från författaren Nagaraju Bandaru. Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
1 741 kr
Kommande
Immunotherapy for Autoimmune Disorders: Innovations and Insights revolutionizes the therapeutic paradigm for autoimmune illnesses, offering new perspectives over traditional medication therapies. This complete and accessible resource examines how immunotherapy teaches the immune system to detect and fight targeted cells, enhancing the body's immune response by providing additional components to strengthen its defense mechanisms. It is essential reading for medical professionals, researchers, and students seeking to learn about immunotherapy as an alternative approach to treating autoimmune disorders. The book covers a wide range of topics, including the pathophysiology, diagnosis, and classification of autoimmune diseases, the immunopathogenesis of these disorders, and the development and application of monoclonal antibodies. It explores immune checkpoint inhibitors, T-cell modulation therapies, cytokine targeting therapies, B-cell depletion strategies, adoptive cell transfer, and regulatory T cells. Additionally, it addresses immunomodulatory agents, small molecules, personalized immunotherapy approaches, and the application of immunotherapeutic strategies for specific autoimmune diseases. Future directions and emerging therapies, as well as regulatory and ethical considerations, are also discussed. Immunotherapy for Autoimmune Disorders: Innovations and Insights bridges the gap between current scientific research and practical clinical applications, leading to better patient outcomes. By supporting academic and clinical research, promoting future innovations, and fostering collaboration among medical professionals, researchers, stakeholders, and policymakers, this book enhances the knowledge and skills necessary for developing advanced and effective treatment options. This ultimately leads to improved patient care and more effective management of autoimmune disorders.Provides in-depth knowledge on the pathophysiology, diagnosis, and treatment of autoimmune diseasesExplores cutting-edge immunotherapy techniques and their applications in autoimmune disorder treatmentBridges the gap between scientific research and clinical practice for better patient managementEnhances academic and clinical research through detailed case studies and clinical trial findingsFosters collaboration among medical professionals, researchers, and policymakers for innovative treatment solutions
1 741 kr
Kommande
Biosimilars and Biologics in Cancer Therapy: An Era in Therapeutic Strategies addresses challenges and opportunities in biosimilars and biologics, integrating the latest evidence, regulatory landscapes, economic implications, and strategies to enhance cancer management. The book aims to create an all-inclusive educational resource, bridge the gap between research and clinical practice, and inspire future research in oncology. It provides a comprehensive examination of cancer therapeutics, starting with an introduction to biologics and biosimilars, their historical development, and foundational principles. Sections explain mechanisms of action, drug development processes, regulatory landscapes, and clinical applications through case studies. Emerging therapeutic strategies, including combination therapies and personalized medicine, are also covered. This book benefits researchers, oncologists, pharmacologists, pathologists, and other healthcare professionals by offering up-to-date insights into the clinical aspects of biological medications and their biosimilars. Contributions from global experts ensure readers gain the latest advancements and practical guidance on integrating these therapies into clinical practice and research.Provides an in-depth analysis of biologics and biosimilars, covering their historical development, mechanisms of action, drug development processes, and regulatory landscapesIncludes case studies and practical examples that highlight the use of biologics and biosimilars in cancer treatment, showcasing their efficacy, safety profiles, and emerging therapeutic strategies such as combination therapies and personalized medicineOffers diverse and comprehensive perspectives, ensuring readers gain insights into the latest advancements and future directions in biosimilars and biologics, along with practical guidance for integrating these therapies into clinical practice and research